NCT06431399招募中1 期
A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004 in Healthy Adult Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- AUCt of JLP-2004
研究概览
简要总结
To evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of JLP-2004
详细描述
A randomized, open-label, crossover phase 1 clinical trial to evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of JLP-2004 in healthy adult volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adult volunteers aged 19 years or older at the time of screening
- •At the time of screening, those who weigh more than 50.0 kg and have a body mass index (BMI) of 18.0 kg/m2 or more and 30.0 kg/m2 or less.
- •Those who do not have congenital or chronic diseases and have no pathological symptoms or findings as a result of internal medical examination (if necessary, electroencephalography, electrocardiogram, chest and stomach endoscopy, or gastrointestinal radiography)
- •Those who be considered suitable for clinical subjects according to the results of laboratory tests (hematology tests, blood chemistry tests, urine tests, serum tests, blood coagulation tests, urine drugs tests), physical examinations and 12-lead electrocardiography at the time of screening
- •Those who voluntarily decide to participate and agree in writing to comply with the subject compliance requirements during the clinical trial period after receiving a detailed explanation of this clinical trial and fully understanding it
排除标准
- •Those who have current or past medical history of clinically significant liver, kidney, nervous system, mental, respiratory, endocrine, blood disease, tumor, genitourinary, cardiovascular, digestive, and musculoskeletal systems, as well as the following symptoms or history.
- •① Renal impairment
- •② Liver disorder
- •For women, pregnant women (Urine-HCG positive) or breastfeeding mother
- •Those who have clinically significant hypersensitivity reactions such as asthma, hives, allergies, etc. to the main ingredient (Pelubiprofen), additives, or other drugs (aspirin or other non-steroidal anti-inflammatory drugs (including COX-2 inhibitors)) and have a history of hypersensitivity reaction
- •Those with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
- •Those with a history of gastrointestinal disease (Crohn's disease, ulcer, acute or chronic pancreatitis, etc.) or gastrointestinal surgery (excluding simple appendectomy or hernia surgery) that may affect the absorption of clinical trial drugs
研究组 & 干预措施
JLP-2004 FAST
Experimental
Thin arm is JLP-2004 FAST condition
干预措施: JLP-2004 qd (Drug)
JLP-2004 FED
Experimental
Thin arm is JLP-2004 FED condition
干预措施: JLP-2004 qd (Drug)
结局指标
主要结局
AUCt of JLP-2004
时间窗: after treatment 0hour, 0.5hour, 1hour, 2hour, 3hour, 24hour
AUCt of JLP-2004 in FAST and FED condition
Cmax of JLP-2004
时间窗: after treatment 0hour, 0.5hour, 1hour, 2hour, 3hour, 24hour
Cmax of JLP-2004 in FAST and FED condition
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese VolunteersHealthy VolunteersNCT05249348PMV Pharmaceuticals, Inc34
已完成
1 期
A Food Effect Study of TAK-385 Final FormulationJapanese Premenopausal Healthy Adult WomenNCT02792062Takeda12
已完成
1 期
AZD 2066 Single Dose Formulation and Food Effect Study in Healthy VolunteersHealthyNCT00690404AstraZeneca20
已完成
1 期
Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male VolunteersHealthyNCT02273427Boehringer Ingelheim24
已完成
1 期
Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With RitonavirHCV InfectionNCT00909311Abbott8